Rehmannioside D
Based on 2 publication(s) in Google Scholar
Rehmannioside D is an orally active Sirt7 modulator. Rehmannioside D upregulates Sirt7 expression, inhibits the level of acetylated p53, and blocks the activation of the p53 signaling pathway. Rehmannioside D alleviates liver injury, inflammatory response, collagen deposition and hepatocyte apoptosis. Rehmannioside D is applicable to research related to liver fibrosis.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 99.89%
- CAS No.: 81720-08-3
- 화학식: C27H42O20
- 분자량:686.61
-
보관:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) Rehmannioside D
MoreAll Caspase Isoforms
More
Biological Activity
Rehmannioside D (5-10 μM; 24 h) alleviates H2O2-induced apoptosis of AML12 cells by upregulating Sirt7 expression[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:H2O2-injured AML12 hepatocytes
-
Concentration:5 μM; 10 μM
-
Incubation Time:24 h (co-incubation with H2O2)
-
Result:Significantly reduced the proportion of apoptotic AML12 cells induced by H2O2, with both 5 μM and 10 μM doses yielding statistically significant effects.
Increased nuclear Sirt7 protein expression, decreased nuclear acetyl-p53 levels, reduced the Bax/Bcl2 ratio, and lowered Cleaved-caspase 3 levels compared to H2O2-only treated cells.
Rehmannioside D (10-40 mg/kg; p.o.; daily; 2 weeks) attenuates DMN-induced liver fibrosis in male Wistar rats by upregulating Sirt7 expression, inhibiting acetyl-p53-mediated hepatocyte apoptosis, reducing hepatic injury, inflammation, and collagen deposition[1].
Rehmannioside D (19-76 mg/kg; i.g.; daily; 2 weeks) has an ameliorative effect in a rat model of impaired ovarian reserve[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J (male, 22-24 g, CCl4-induced liver fibrosis model)[1]
-
Dosage:10 mg/kg; 40 mg/kg
-
Administration:i.g.; daily; 3 weeks
-
Result:Significantly reduced serum ALT and AST activities compared to CCl4-induced controls.
Ameliorated liver histopathological damage, including reduced lobule structural distortion, hepatocellular swelling/necrosis, and inflammatory cell infiltration.
Decreased F4/80-positive macrophage area and downregulated hepatic mRNA expression of inflammatory genes (Adgre1, Tnfα, Il1β, Ccl2) compared to CCl4-induced controls.
Reduced collagen deposition.
Reduced the number of TUNEL+/HNF4α+ hepatocytes compared to CCl4-induced controls.
Restored hepatic Sirt7 expression, reduced nuclear acetyl-p53 levels, lowered the Bax/Bcl2 ratio, and decreased Cleaved-caspase 3 levels compared to CCl4-induced controls.
-
Animal Model:SD rats (female, 8 weeks old, Cyclophosphamide (HY-17420) induced DOR)[3]
-
Dosage:19 mg/kg, 38 mg/kg, 76 mg/kg
-
Administration:i.g.; daily; 2 weeks
-
Result:Notably recovered disordered estrous cycles and increased ovarian index of DOR rats.
Elevated the quantity of primordial and mature follicles while reducing atretic follicle count via ovarian histomorphology observation.
Downregulated abnormally high FSH and LH concentrations and upregulated declined E2 level.
Decreased granulosa cell apoptotic rate and upregulated FOXO1 expression.
Chemical Information
-
CAS No. 81720-08-3
-
Appearance Solid
-
분자량 686.61
-
화학식 C27H42O20
-
Color White to off-white
-
SMILES
O[C@H]1[C@@]([C@](C(CO)=C1)([H])[C@@H]2O[C@]([C@@H]([C@@H](O)[C@@H]3O)O)([H])O[C@@H]3CO)(C=CO2)O[C@@](O[C@H](CO)[C@@H](O)[C@@H]4O)([H])[C@@H]4O[C@]([C@@H]([C@@H](O)[C@@H]5O)O)([H])O[C@@H]5CO
-
Structure Classification
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Phytomedicine
Rehmannioside D prevents estrogen-deficiency induced osteoporosis by interacting with c-Jun to dismantle the AP-1 complex and suppress MAPK/NF-κB signaling. [Abstract]2026 Aug:158:158371. PMID: 42251792 -
J Ethnopharmacol
Protecting the brain from stroke: Huoxue Rongluo formula (HXRLF) targets ferroptosis for neuroprotection. [Abstract]2025 Jul 29;353(Pt A):120329. PMID: 40744419
용액&용해도
H2O : 100 mg/mL (145.64 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
순도&문서
-
Data Sheet (287 KB)
-
SDS (392 KB)
- English - EN (392 KB)
- Français - FR (392 KB)
- Deutsch - DE (392 KB)
- Norwegian - NO (392 KB)
- Español - ES (392 KB)
- Swedish - SV (392 KB)
- Italian - IT (392 KB)
- Korean - KR (392 KB)
- Portuguese - PT (392 KB)
-
Handling Instructions (2659 KB)
References
[1]. Liang Y, et al. Rehmannioside D ameliorates hepatocyte apoptosis and liver fibrosis by suppressing Sirt7/p53 axis. J Ethnopharmacol. 2026;357:120863. [Content Brief]
[2]. Liu W, et al. Phytochemical Profiles and Antioxidant Activity of Rehmannia glutinosa from Different Production Locations. Chem Biodivers. 2020;17(8):e2000341. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 1.4564 mL | 7.2822 mL | 14.5643 mL | 36.4108 mL |
| 5 mM | 0.2913 mL | 1.4564 mL | 2.9129 mL | 7.2822 mL | |
| 10 mM | 0.1456 mL | 0.7282 mL | 1.4564 mL | 3.6411 mL | |
| 15 mM | 0.0971 mL | 0.4855 mL | 0.9710 mL | 2.4274 mL | |
| 20 mM | 0.0728 mL | 0.3641 mL | 0.7282 mL | 1.8205 mL | |
| 25 mM | 0.0583 mL | 0.2913 mL | 0.5826 mL | 1.4564 mL | |
| 30 mM | 0.0485 mL | 0.2427 mL | 0.4855 mL | 1.2137 mL | |
| 40 mM | 0.0364 mL | 0.1821 mL | 0.3641 mL | 0.9103 mL | |
| 50 mM | 0.0291 mL | 0.1456 mL | 0.2913 mL | 0.7282 mL | |
| 60 mM | 0.0243 mL | 0.1214 mL | 0.2427 mL | 0.6068 mL | |
| 80 mM | 0.0182 mL | 0.0910 mL | 0.1821 mL | 0.4551 mL | |
| 100 mM | 0.0146 mL | 0.0728 mL | 0.1456 mL | 0.3641 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.